BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9568286)

  • 21. 3-Alkylamino-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells: design, synthesis, and pharmacological evaluation.
    Pirotte B; Ouedraogo R; de Tullio P; Khelili S; Somers F; Boverie S; Dupont L; Fontaine J; Damas J; Lebrun P
    J Med Chem; 2000 Apr; 43(8):1456-66. PubMed ID: 10780901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological activity of novel 2-(alpha-alkoxyimino)benzylpyridine derivatives as K+ channel openers.
    Maekawa T; Yamamoto S; Igata Y; Ikeda S; Watanabe T; Shiraishi M
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):1994-2004. PubMed ID: 9433769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
    Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
    J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasorelaxing properties of some phenylacridine type potassium channel openers in isolated rabbit thoracic arteries.
    Berkan O; Saraç B; Simşek R; Yildirim S; Sarioğlu Y; Safak C
    Eur J Med Chem; 2002 Jun; 37(6):519-23. PubMed ID: 12204478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological activity of spirocyclic benzopyran imidazolone potassium channel openers.
    Gadwood RC; Kamdar BV; Dubray LA; Wolfe ML; Smith MP; Watt W; Mizsak SA; Groppi VE
    J Med Chem; 1993 May; 36(10):1480-7. PubMed ID: 8496916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular pharmacology of SKP-450, a new potassium channel activator, and its major metabolites SKP-818 and SKP-310.
    Shin HS; Seo HW; Yoo SE; Lee BH
    Pharmacology; 1998 Mar; 56(3):111-24. PubMed ID: 9532610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
    Atwal KS
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.
    Perez-Vizcaino F; Casis O; Rodriguez R; Gomez LA; Garcia Rafanell J; Tamargo J
    Br J Pharmacol; 1993 Nov; 110(3):1165-71. PubMed ID: 8298804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of Ki1769, a novel vasodilator, in isolated rat aorta.
    Kashiwabara T; Nakajima T; Kasai H; Nakajima S; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):175-83. PubMed ID: 7979826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a novel K+ channel activator, EMD 52962, in electrophysiological and pharmacological experiments.
    De Peyer JE; Lues I; Gericke R; Häusler G
    Pflugers Arch; 1989; 414 Suppl 1():S191. PubMed ID: 2780258
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.
    Triggle CR; Li YQ; Wyse DG
    Proc West Pharmacol Soc; 1992; 35():97-102. PubMed ID: 1502246
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardioselective antiischemic ATP-sensitive potassium channel openers. 4. Structure-activity studies on benzopyranylcyanoguanidines: replacement of the benzopyran portion.
    Atwal KS; Ferrara FN; Ding CZ; Grover GJ; Sleph PG; Dzwonczyk S; Baird AJ; Normandin DE
    J Med Chem; 1996 Jan; 39(1):304-13. PubMed ID: 8568821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Action of KC-399, a newly synthesized potassium channel opener, on mechanical activity and 86Rb efflux in rat aorta.
    Tamura K; Suzuki Y; Yoshida S; Nabata H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):220-6. PubMed ID: 7511750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of effects of a potassium channel opener BRL34915, a specific potassium ionophore valinomycin and calcium channel blockers on endothelin-induced vascular contraction.
    Kim S; Morimoto S; Koh E; Miyashita Y; Ogihara T
    Biochem Biophys Res Commun; 1989 Nov; 164(3):1003-8. PubMed ID: 2511839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the effects and interactions of cromakalim and glibenclamide in cardiac and vascular tissues.
    BoSmith RE; Briggs I; Grant TL; Grimwood S; Russell NJ; Stone MA; Wickenden AD
    Pflugers Arch; 1989; 414 Suppl 1():S190. PubMed ID: 2506523
    [No Abstract]   [Full Text] [Related]  

  • 36. K(+)-channel activators in vascular smooth muscle.
    Cox RH
    Prog Clin Biol Res; 1990; 334():171-85. PubMed ID: 2309006
    [No Abstract]   [Full Text] [Related]  

  • 37. 6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysis.
    Mannhold R; Cruciani G; Weber H; Lemoine H; Derix A; Weichel C; Clementi M
    J Med Chem; 1999 Mar; 42(6):981-91. PubMed ID: 10090781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syntheses and biological activities of potent potassium channel openers derived from (+/-)-2-oxo-1-pyridin-3-yl-cyclohexanecarbothioic acid methylamide: new potassium channel openers.
    Brown TJ; Chapman RF; Mason JS; Palfreyman MN; Vicker N; Walsh RJ
    J Med Chem; 1993 May; 36(11):1604-12. PubMed ID: 8496928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relaxant activity in rat aorta and trachea, conversion to a muscarinic receptor antagonist and structure-activity relationships of new K(ATP) activating 6-varied benzopyrans.
    Lemoine H; Weber H; Derix A; Uhrig U; Höltje HD; Mannhold R
    Eur J Pharmacol; 1999 Jul; 378(1):85-97. PubMed ID: 10478568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative relaxant effects of cromakalim and pinacidil on the tonic contraction of canine coronary artery induced by phorbol 12,13-dibutylate.
    Kuromaru O; Sakai K
    Clin Exp Pharmacol Physiol; 1996; 23(6-7):493-7. PubMed ID: 8800572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.